AposHealth® is a medical device company owned by aMoon, operating in the USA, the United Kingdom, Singapore, and Israel. Their mission is to revolutionize the treatment of musculoskeletal conditions by addressing people's gait to alleviate pain, improve mobility, and enhance overall well-being. AposHealth® offers a flagship solution called Apos®, which is CE-marked and FDA-cleared to temporarily reduce knee pain caused by osteoarthritis.

This innovative system, used by over 120,000 patients and backed by over 60 peer-reviewed studies, includes gait analysis, a personalized foot-worn device, and a customized treatment plan. With a remarkable 96% satisfaction rate, Apos® not only helps patients with knee pain but also provides relief for chronic lower back and hip pain. Additionally, NICE (National Institute for Health and Care Excellence) recommends Apos® for individuals with knee osteoarthritis.

AposHealth® is committed to restoring function and mobility through advanced motion analysis, enabling individuals to live an active and fulfilling life